Last reviewed · How we verify
NCT04000178
OPTIMAL STENTS DURING RENAL COLIC
NA trial testing polyurethane stent in Ureteral Stent Occlusion in 50 participants. Completed in 10 October 2018.
10 October 2018
Quick facts
| Lead sponsor | St. Petersburg State Pavlov Medical University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 1 June 2018 |
| Primary completion | 10 October 2018 |
| Estimated completion | 10 October 2018 |
| Sites | 1 location across Russia |
Drugs / interventions tested
- polyurethane stent
- silicone stent
Conditions studied
- Ureteral Stent Occlusion — all drugs for Ureteral Stent Occlusion →
Sponsor
St. Petersburg State Pavlov Medical University
Who can join
Adults 18 to 60, any sex, with Ureteral Stent Occlusion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
From June 2018 to October 2018, patients from two distinct clinical centers were prospectively enrolled in the study and stratified (non-randomly) into either control group A, patients who received polyurethane stents (Rüsch, Teleflex), or experimental group B, patients who received silicone stents (Cook Medical). Each participant completed a survey one hour after stent insertion, in the middle of the stent dwelling period, and before stent removal or ureteroscopy noting body pain and overactive bladder via the visual analog scale pain (VASP) and overactive bladder (OAB) awareness tool, respectively. Additionally, the successfulness of stent placement, hematuria, number of unplanned visits, and stent encrustation rates were assessed within each group.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison of silicone versus polyurethane ureteral stents: a prospective controlled study.
Gadzhiev N, Gorelov D, Malkhasyan V, Akopyan G, et al · · 2020 · cited 26× · PMID 32013936 · DOI 10.1186/s12894-020-0577-y
Verify or expand the search:
- PubMed search for NCT04000178
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Ureteral Stent Occlusion
Currently open trials in the same condition.
- NCT05455307 — Efficacy and Safety of Allium Ureteral Stent for Treating Refractory Ureteral Stricture · NA · recruiting
Other St. Petersburg State Pavlov Medical University trials
Trials by the same sponsor.
- NCT07238712 — Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies · Phase 2 · recruiting
- NCT06871007 — Nivolumab and DA-EPOCH-R in Pediatric Primary Mediastinal (Thymic) Large B-cell Lymphoma · Phase 1, PHASE2 · enrolling by invitation
- NCT05757466 — Prolgolimab Monotherapy or in Combination With Bendamustine for r/r Classical Hodgkin Lymphoma · Phase 2 · unknown
- NCT06022952 — The Impact of the "Stone MD" Mobile App on the Prevention of Forgotten Ureteral Stents · NA · unknown
- NCT05591716 — Evaluation of the Efficacy and Safety of Unimodal Bilateral Flexible Ureteroscopy. · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04000178 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by St. Petersburg State Pavlov Medical University
- Last refreshed: 13 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04000178.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing